Accuray Incorporated to Speak at UBS Global Life Sciences Conference(2)
SUNNYVALE, Calif., Sept. 16, 2011 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the UBS Global Life Sciences Conference in New York on Tuesday, September 20, 2011 at 4:30 p.m. ET/1:30 p.m. PT.
A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.
Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is the premier radiation oncology company. Accuray develops, manufactures and sells personalized, innovative treatment solutions that revolve around the patient. Accuray's game-changing technologies – the CyberKnife System and TomoTherapy System – set the standard of care with the aim of helping patients live longer, better lives. To date, more than 200,000 patients worldwide have been treated using the company's technologies and more than 550 systems have been installed in leading hospitals around the world. For more information, please visit www.accuray.com.